Ontology highlight
ABSTRACT: Objective
Recently, mutations in DCTN1 were found to cause Perry syndrome, a parkinsonian disorder with TDP-43-positive pathology. Previously, mutations in DCTN1 were identified in a family with lower motor neuron disease, in amyotrophic lateral sclerosis (ALS), and in a family with ALS/frontotemporal dementia (FTD), suggesting a central role for DCTN1 in neurodegeneration.Methods
In this study we sequenced all DCTN1 exons and exon-intron boundaries in 286 samples diagnosed with Parkinson disease (PD), frontotemporal lobar degeneration (FTLD), or ALS.Results
This analysis revealed 36 novel variants (9 missense, 5 silent, and 22 noncoding). Segregation analysis in families and association studies in PD, FTLD, and ALS case-control series did not identify any variants segregating with disease or associated with increased disease risk.Conclusions
This study suggests that pathogenic mutations in DCTN1 are rare and do not play a common role in the development of Parkinson disease, frontotemporal lobar degeneration, or amyotrophic lateral sclerosis.
SUBMITTER: Vilarino-Guell C
PROVIDER: S-EPMC2692178 | biostudies-literature | 2009 Jun
REPOSITORIES: biostudies-literature
Vilariño-Güell C C Wider C C Soto-Ortolaza A I AI Cobb S A SA Kachergus J M JM Keeling B H BH Dachsel J C JC Hulihan M M MM Dickson D W DW Wszolek Z K ZK Uitti R J RJ Graff-Radford N R NR Boeve B F BF Josephs K A KA Miller B B Boylan K B KB Gwinn K K Adler C H CH Aasly J O JO Hentati F F Destée A A Krygowska-Wajs A A Chartier-Harlin M-C MC Ross O A OA Rademakers R R Farrer M J MJ
Neurology 20090601 23
<h4>Objective</h4>Recently, mutations in DCTN1 were found to cause Perry syndrome, a parkinsonian disorder with TDP-43-positive pathology. Previously, mutations in DCTN1 were identified in a family with lower motor neuron disease, in amyotrophic lateral sclerosis (ALS), and in a family with ALS/frontotemporal dementia (FTD), suggesting a central role for DCTN1 in neurodegeneration.<h4>Methods</h4>In this study we sequenced all DCTN1 exons and exon-intron boundaries in 286 samples diagnosed with ...[more]